A new study in Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Laurus aims to leverage India's manufacturing prowess to serve global cell and gene therapy players targeting the Indian ...

Roche Holding AG will invest $50 billion in pharmaceuticals and diagnostics in the US in the next five years, as the Swiss ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, today announced that Christopher Hepler, ...

Abeona Therapeutics' pz-cel gene therapy shows the most durable wound healing in RDEB patients. See why I rate ABEO stock a ...

A new paper published in Gene Therapy raises serious concerns about the effectiveness of gene therapy for Duchenne muscular ...

Gene therapy represents one of the fastest growing biotherapeutics worldwide, with AAV at the forefront. This rapid growth is ...

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 10.12%, which has investors questioning if this is right time to ...

Lexeo Therapeutics, Inc.’s LXEO share price has surged by 9.50%, which has investors questioning if this is right time to ...